Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. The guidelines development tool, the Practice Guidelines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback